Disease taxonomy--monogenic muscular dystrophy.

Area of Science:

• Genetics and Molecular Biology
• Neuromuscular Disorders
• Biochemistry

Background:

• Autosomal recessive progressive muscular dystrophies (AR-PMDs) classification has been historically challenging.
• Advances in genetic and molecular etiology are providing a clearer understanding of these conditions.
• Previous research focused on structural proteins, particularly those associated with dystrophin.

Purpose of the Study:

• To review recent genetic and molecular findings in AR-PMDs.
• To discuss the implications of these findings for disease classification (nosology).
• To explore the potential for distinct pathophysiological pathways (structuropathy vs. enzymopathy) and complex inheritance models.

Main Methods:

• Review of recent genetic and molecular etiological studies of AR-PMDs.
• Analysis of the roles of structural proteins and enzymes (e.g., calpain protease) in disease pathogenesis.
• Discussion of genetic inheritance patterns, including potential epistatic interactions.

Main Results:

• Genetic elucidation has significantly advanced the understanding and classification of AR-PMDs.
• Most AR-PMDs involve structural proteins linked to dystrophin, but Réunion-type limb girdle muscular dystrophy involves a calpain protease.
• This suggests potential distinct pathways (structuropathy vs. enzymopathy) leading to similar phenotypes.
• Evidence indicates that classical monogenic inheritance models may be too simplistic, with potential epistatic interactions.

Conclusions:

• Genetics provides an objective basis for a refined nosology of AR-PMDs.
• The discovery of a protease in muscular dystrophy challenges the view of a single pathway, suggesting multiple mechanisms.
• Future research should consider complex inheritance models and the identification of genes for multifactorial traits.